Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3011436	s-histab	— (—)	844	917	100.00%	Distribution not available
3011436	s-histab	u/ml (u/ml)	25	30	50.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

23.40

73.44

1.0

—

u/ml

—

Fibromyalgia

8.56

30.50

1.1

—

ILD, hospital admission 2, with pulmonary infections

7.52

26.73

1.1

—

u/ml

—

Asthma (only as main-diagnosis), excluding more controls

138

283

2.91

25.99

1.1

—

19.40

u/ml

—

Asthma (only as main-diagnosis)

138

298

2.80

24.42

1.1

—

19.40

u/ml

—

Polyarthrosis

5.06

24.02

1.2

1.0

—

Asthma, excluding more controls

145

283

2.74

23.68

1.0

1.1

—

19.40

u/ml

—

Asthma

149

298

2.69

23.60

1.0

1.1

—

19.40

u/ml

—

Asthma (mode)

146

304

2.64

22.61

1.0

1.1

—

19.40

u/ml

—

Other peripheral vascular diseases

6.21

18.92

1.1

—

u/ml

—

Infections, IBD-co-morbidities

7.06

16.89

1.1

1.0

—

Sciatica+with lumbago

376

2.48

15.59

1.1

—

37.60

u/ml

—

Gastro-oesophageal reflux disease

127

508

2.22

15.49

1.1

—

40.57

u/ml

—

Pneumonia due to other infectious organisms, not elsewhere classified

12.65

15.16

1.0

1.2

—

Sleep disorders (combined)

180

603

1.96

14.91

1.1

—

36.88

u/ml

—

Sleep apnoea

164

559

1.99

14.38

1.1

—

39.43

u/ml

—

Asthma (diagnoses ohter than nonallergic)

156

672

1.99

14.26

1.1

—

31.00

u/ml

—

Other intervertebral disc disorders

146

433

2.07

13.81

1.1

—

37.60

—

Asthma-related infections

105

462

2.24

13.45

1.1

—

31.00

u/ml

—

Asthma, hospital admission 2, infections

105

462

2.24

13.45

1.1

—

31.00

u/ml

—

Other necrotizing vasculopathies

6.15

12.93

1.2

1.1

—

Sleep apnoea, including avohilmo

168

575

1.90

12.76

1.1

—

39.43

u/ml

—

Disorders of lacrimal system

356

2.39

12.75

1.1

—

42.33

u/ml

—

Disorders of thyroid, IBD co-morbidities

5.89

12.48

1.1

1.0

—

Erythema multiforme

12.16

11.76

1.2

—

u/ml

—

Lumbar disc prolapse

108

413

2.08

11.14

1.1

—

37.60

—

Dermatitis due to substances taken internally

7.54

10.56

1.2

1.1

—

u/ml

—

Polyarthritis, unspecified

10.08

10.45

1.2

1.0

—

u/ml

—

Gout

110

3.24

10.17

1.1

1.0

—

u/ml

—

Asthma, hospital admissions , main diagnosis only

139

684

1.82

10.03

1.1

—

31.00

u/ml

—

351

2.18

9.40

1.1

—

33.62

u/ml

—

Juvenile rheumatoid arthirtis

21.95

9.36

1.1

1.0

—

Complications of surgical and medical care, not elsewhere classified

160

664

1.73

9.35

1.1

—

36.88

u/ml

—

Vasomotor and allergic rhinitis

289

2.25

8.76

1.0

1.1

—

27.29

—

Atrial fibrillation and flutter with reimbursement

2.85

8.51

1.1

—

Carpal tunnel syndrome

102

485

1.90

8.49

1.1

—

45.33

u/ml

—

Alopecia areata

8.54

8.47

1.0

1.2

—

Other CVD (FINNGEN)

4.03

8.23

1.1

—

Heart failure and antihypertensive medication

107

2.72

7.91

1.1

—

Asthma, including avohilmo

184

666

1.61

7.90

1.1

—

28.45

u/ml

—

6-mercaptopurine

15.13

7.72

1.2

1.1

—

Certolizumab pegol

13.56

7.41

1.3

1.2

—

u/ml

—

Complications of procedures, not elsewhere classified

126

641

1.70

7.28

1.1

—

36.88

u/ml

—

Undetermined asthma, excluding more controls

3.49

7.24

1.0

1.1

—

Renal tubulo-interstitial diseases

133

607

1.68

7.23

1.1

—

31.00

u/ml

—

Gonarthrosis,primary

137

512

1.68

7.22

1.1

—

24.00

—

Allergic rhinitis

226

2.28

7.19

1.0

1.1

—

30.17

—

Undetermined asthma

3.44

7.09

1.0

1.1

—

Complications of medical and surgical care

113

626

1.72

6.87

1.1

—

36.88

u/ml

—

Intracranial trauma

315

1.90

6.53

1.1

—

39.29

u/ml

—

Psoriasis (vulgaris), strict definition

6.16

6.43

1.4

1.1

—

u/ml

—

Hypertensive Renal Disease

6.15

6.43

1.0

1.1

—

Migraine

364

1.87

6.41

1.1

—

31.33

u/ml

—

Irritable bowel syndrome

222

2.21

6.35

1.0

1.1

—

47.00

u/ml

—

Any operation in hilmo

+∞

6.28

1.1

0.0

—

Vocal cord dysfunction

3.68

6.12

1.0

1.1

—

u/ml

—

Bruxism

6.33

5.97

1.0

1.1

—

Concussion

301

1.93

5.92

1.1

—

39.29

u/ml

—

TMD related pain

5.54

5.81

1.1

—

Osteopathies and chondropathies

453

1.76

5.68

1.1

—

24.40

—

Other hammer toe(s) (acquired)

2.84

5.61

1.1

1.0

—

Chronic sinusitis

351

1.88

5.58

1.0

1.1

—

39.43

—

Bleeding

116

521

1.62

5.55

1.1

—

25.50

u/ml

—

Symptoms and signs involving the digestive system and abdomen

147

478

1.54

5.31

1.1

—

28.45

u/ml

—

Osteoporosis with pathological fracture (FG)

4.21

5.09

1.1

1.0

—

Other headache syndromes

365

1.81

4.99

1.0

1.1

—

39.43

u/ml

—

Nausea and vomiting

182

2.16

4.99

1.1

—

47.00

u/ml

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

500

1.68

4.92

1.1

—

37.71

u/ml

—

Other specified/unspecified necrotizing vasculopathies

11.59

4.80

1.0

1.3

—

Other nutritional deficiencies

581

1.60

4.59

1.1

—

36.88

u/ml

—

Acute sinusitis

411

1.70

4.59

1.1

—

22.40

—

Pyogenic arthritis

4.41

4.56

1.1

1.0

—

Chronic diseases of tonsils and adenoids

115

471

1.55

4.50

1.1

—

32.33

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

535

1.62

4.47

1.1

—

36.88

u/ml

—

Other functional intestinal disorders

325

1.79

4.45

1.1

—

20.83

—

Migraine with aura

175

2.12

4.42

1.1

—

33.80

u/ml

—

Abdominal and pelvic pain

141

478

1.48

4.36

1.1

—

28.45

u/ml

—

Obesity and other hyperalimentation

562

1.59

4.25

1.1

—

36.88

u/ml

—

Obesity

560

1.58

4.10

1.1

—

36.88

u/ml

—

Other abnormal uterine and vaginal bleeding

136

2.05

4.04

1.1

—

Drug-induced systemic lupus erythematosus

10.25

4.03

1.4

1.3

—

Dermatopolymyositis

10.11

4.02

1.0

1.1

—

u/ml

—

Ischemic heart diseases

109

450

1.52

3.97

1.1

—

26.80

u/ml

—

Hernia

130

609

1.45

3.84

1.1

—

36.87

u/ml

—

Other symptoms and signs involving the circulatory and respiratory systems

3.54

3.76

1.4

1.2

—

Reactive arthropathies

3.34

3.76

1.2

1.0

—

Disorders of other endocrine glands

359

1.67

3.61

1.0

1.1

—

39.67

u/ml

—

Disorders of the thyroid gland

131

600

1.43

3.59

1.1

—

23.67

u/ml

—

Obesity due to excess calories

412

1.63

3.58

1.1

—

37.71

u/ml

—

Ischaemic heart disease, wide definition

106

447

1.48

3.53

1.1

—

26.80

u/ml

—

Constipation

119

591

1.44

3.51

1.1

—

36.88

—

Drug-induced osteoporosis with pathological fracture

10.10

3.50

1.2

—

Crystal arthropathies, rheuma endpoint

10.08

3.50

1.0

—

Other crystal arthropathies

10.08

3.50

1.0

—

Hard cardiovascular diseases

106

465

1.46

3.33

1.1

—

26.80

u/ml

—

Prurigo nodularis

8.62

3.26

1.2

1.1

—

Hypermobility syndrome

3.58

3.19

1.2

1.1

—

u/ml

—

Artificial joint operation, meniscal resection

120

565

1.41

3.17

1.1

—

24.00

—

Puerperal sepsis

112

2.15

3.05

1.2

1.1

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

5.86

3.02

1.3

1.0

—

Later onset COPD, excluding more controls

2.26

3.01

1.0

1.1

—

Other general symptoms and signs

4.06

2.85

1.0

—

Secondary hypertension

2.95

2.64

1.0

1.2

—

Intracranial injury

462

1.49

2.64

1.1

—

19.67

u/ml

—

Dizziness and giddiness

567

1.40

2.64

1.0

1.1

—

23.29

—

Pulmonary eosinophilia, not elsewhere classified

7.21

2.55

1.2

1.1

—

Erythema nodosum

4.40

2.47

1.0

1.1

—

Causalgia

6.29

2.37

1.2

1.1

—

Malnutrition

6.28

2.37

1.0

1.3

—

u/ml

—

Acute tubulo-interstitial nephritis

480

1.42

2.31

1.1

—

33.63

u/ml

—

Temporal arteritis

4.63

2.27

1.3

1.1

—

Paroxysmal tachycardia

119

1.85

2.22

1.1

—

Excessive attrition of teeth

200

1.52

2.16

1.0

1.1

—

21.50

u/ml

—

Other and unspecified disease of Bartholin gland

3.70

2.15

1.0

1.2

—

Benign neoplasm: Other/unspecified site

5.03

2.07

1.2

1.1

—

Hallux rigidus

2.26

2.07

1.1

1.0

—

Tonsillectomy and adenotomy

343

1.42

2.06

1.2

1.1

—

26.25

u/ml

—

Giant cell arteritis

4.01

2.04

1.3

1.1

—

Pneumonia due to Streptococcus pneumoniae

4.01

2.04

1.0

1.1

—

Oligomenorrhoea

3.34

1.96

1.3

1.0

—

Atopic dermatitis, strict definition

220

1.61

1.96

1.1

—

30.17

u/ml

—

Hyperhidrosis

4.56

1.94

1.0

1.1

—

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

3.77

1.93

1.2

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

2.45

1.93

1.2

1.1

—

u/ml

—

Appendectomy

601

1.35

1.90

1.1

—

36.88

u/ml

—

Diseases of middle ear and mastoid

412

1.39

1.90

1.1

—

26.29

u/ml

—

Varicose veins

450

1.36

1.90

1.1

—

24.00

u/ml

—

Anxiety (asthma-related co-morbidities)

451

1.36

1.87

1.1

—

13.71

u/ml

—

Other disorders of urethra and urinary system

516

1.32

1.78

1.1

—

33.22

u/ml

—

Benign neoplasms

103

446

1.31

1.78

1.1

—

24.25

u/ml

—

Retained placenta and membranes, without haemorrhage

1.93

1.74

1.2

1.1

—

Other aneurysm

2.67

1.72

1.1

—

Other specified/unspecified soft tissue disorders

2.92

1.72

1.0

—

Lung cancer and mesothelioma

1.90

1.72

1.0

1.1

—

Benign neoplasm: Other/unspecified site

3.87

1.72

1.2

1.0

—

Other deformities of toe(s)

3.86

1.71

1.0

—

Algoneurodystrophy

3.17

1.66

1.2

1.1

—

Parodontitis, under 40 years

2.25

1.63

1.0

1.1

—

Parodontitis, under 40 years, or operation codes

2.25

1.63

1.0

1.1

—

Cholelithiasis

105

577

1.28

1.61

1.0

1.1

—

34.50

u/ml

—

Flat foot [pes planus] (acquired)

2.33

1.60

1.2

1.0

—

Cholelithiasis, broad definition with cholecystitis

108

583

1.27

1.58

1.1

—

34.50

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

117

606

1.26

1.57

1.1

—

39.43

u/ml

—

Other diseases of stomach and duodenum

2.43

1.53

1.0

1.1

—

u/ml

—

Diabetes, varying definitions

130

627

1.24

1.53

1.1

—

36.88

u/ml

—

Unspecified chronic bronchitis

3.34

1.52

1.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

120

574

1.25

1.51

1.1

—

39.43

u/ml

—

Type 2 diabetes

125

598

1.24

1.50

1.1

—

39.43

u/ml

—

Benign neoplasms

125

562

1.24

1.49

1.1

—

24.40

u/ml

—

Unspecified fall

398

1.37

1.47

1.1

—

21.20

u/ml

—

Diabetic retinopathy, excluding more controls

1.61

1.47

1.1

—

u/ml

—

Diabetes mellitus

130

631

1.23

1.44

1.1

—

36.88

u/ml

—

Type 2 diabetes, definitions combined

119

572

1.24

1.44

1.1

—

39.43

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP)

2.12

1.44

1.2

1.1

—

u/ml

—

All dysplastic lesions of the vagina

3.14

1.44

1.2

1.1

—

Other disorders of veins

352

1.39

1.44

1.1

—

26.80

—

Cardiac arrest

2.52

1.43

1.0

1.1

—

Acute suppurative otitis media

168

1.56

1.41

1.0

1.1

—

30.17

u/ml

—

Medical abortion

381

1.27

1.31

1.0

1.1

—

37.71

u/ml

—

Pustulosis palmaris et plantaris

2.51

1.30

1.0

—

Emphysema

2.36

1.29

1.0

1.1

—

Myocarditis

2.40

1.24

1.3

1.2

—

u/ml

—

Polycystic ovarian syndrome

2.23

1.24

1.0

1.1

—

Type 2 diabetes, wide definition

492

1.25

1.23

1.1

—

26.80

u/ml

—

Type 2 diabetes, definitions combined, including avohilmo

118

574

1.22

1.23

1.1

—

39.43

u/ml

—

Other disorders of amniotic fluid and membranes

1.70

1.23

1.2

1.1

—

u/ml

—

Female infertility, associated with anovulation

2.04

1.22

1.1

—

Parodontitis, under 40 years and operation codes

2.04

1.22

1.0

1.1

—

Parodontitis, operation under 40 years and operation codes

2.04

1.22

1.0

1.1

—

Nonsuppurative otitis media

135

1.54

1.17

1.3

1.1

—

9.80

u/ml

—

Ovarian dysfunction

2.00

1.16

1.1

—

Open bite

2.26

1.10

1.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

487

1.22

1.08

1.1

—

26.78

u/ml

—

Bronchiectasis

1.93

1.06

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

398

1.30

1.03

1.1

—

28.57

u/ml

—

Recurrent dislocation of patella

2.28

1.03

1.0

1.1

—

Twin gestation

1.84

1.02

1.1

—

Excessive vomiting in pregnancy

1.77

1.00

1.3

1.1

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

2.00

1.00

1.0

—

Respiratory insufficiency

2.00

0.99

1.0

1.1

—

Injuries to the shoulder and upper arm

646

1.21

0.99

1.1

—

33.11

u/ml

—

Disorders of vitreous body and globe

429

1.27

0.98

1.1

—

26.80

—

Neoplasms

423

1.20

0.94

1.1

—

24.25

u/ml

—

Multiple gestation

1.78

0.94

1.1

—

Obesity, other/unspecified

286

1.33

0.92

1.0

1.1

—

37.00

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.75

0.90

1.2

1.1

—

u/ml

—

Other (not insulin) diabetes medications

115

593

1.17

0.86

1.1

—

39.43

u/ml

—

Postmenopausal osteoporosis with pathological fracture

1.78

0.84

1.1

1.0

—

Other obstructed labour

1.69

0.82

1.2

1.1

—

Suppurative and unspecified otitis media

269

1.29

0.77

1.0

1.1

—

30.17

u/ml

—

Failed induction of labour

1.77

0.76

1.0

1.1

—

Multiple delivery

1.70

0.75

1.1

—

Cyst of Bartholin Gland

2.09

0.74

1.0

1.1

—

Acute appendicitis, no complications

521

1.21

0.74

1.0

1.1

—

32.29

u/ml

—

Disorders of vitreous body

423

1.23

0.73

1.1

—

26.80

—

Female infertility, tubal origin

2.00

0.72

1.2

1.1

—

Amenorrhoea

1.75

0.71

1.3

1.1

—

Placenta praevia

1.85

0.68

1.2

1.1

—

Autoimmune hyperthyroidism

1.85

0.68

1.0

—

Asthma mixed form (mode)

1.85

0.68

1.2

1.1

—

Diabetic nephropathy, excluding more controls

1.53

0.67

1.1

—

Infections of breast associated with childbirth

1.79

0.66

1.0

1.1

—

Asthma mixed form (mode), excluding more controls

1.79

0.66

1.2

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.57

0.65

1.2

1.1

—

u/ml

—

Disorders of adult personality and behaviour

216

1.30

0.63

1.0

1.1

—

30.17

u/ml

—

Arterial embolism and thrombosis

1.67

0.61

1.0

1.1

—

Other noninflammatory disorders of vagina

1.57

0.60

1.1

—

Cholecystectomy

597

1.16

0.59

1.0

1.1

—

39.43

u/ml

—

Diabetes medication

119

643

1.12

0.58

1.1

—

36.88

u/ml

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.58

0.0

1.0

—

Other sexually transmitted chlamydial diseases

1.54

0.53

1.0

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

114

624

1.12

0.52

1.1

—

36.88

—

Other and unspecified disorders of vitreous body

358

1.20

0.51

1.1

—

26.80

—

Biguanides

108

596

1.12

0.50

1.1

—

39.43

u/ml

—

Procreative management

204

1.24

0.50

1.1

—

9.40

u/ml

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

107

585

1.12

0.50

1.1

—

36.88

—

Gestational diabetes (for exclusion)

245

0.81

0.48

1.1

—

36.60

u/ml

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.41

0.46

1.3

1.1

—

Diabetes mellitus in pregnancy

195

0.80

0.46

1.1

—

36.60

u/ml

—

Diabetic nephropathy

101

1.37

0.46

1.1

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

0.60

0.45

1.0

1.1

—

Other disorders of breast

112

1.34

0.44

1.1

—

Inflammatory disease of uterus

104

1.35

0.43

1.3

1.1

—

Recurrent dislocation and subluxation of joint

1.61

0.43

1.0

—

Acute appendicitis

631

1.12

0.42

1.0

1.1

—

36.88

u/ml

—

Behavioural syndromes associated with physiological disturbances and physical factors

258

1.20

0.41

1.0

1.1

—

30.17

—

Autism spe

0.00

0.41

0.0

1.1

—

Autism

0.00

0.41

0.0

1.1

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

0.41

0.0

1.1

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

0.40

0.0

1.1

—

Wide developmental disorders

0.00

0.40

0.0

1.1

—

Postpartum haemorrhage

186

1.22

0.39

1.1

—

36.60

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1.38

0.38

1.0

1.1

—

Diseases of appendix

659

1.11

0.37

1.0

1.1

—

36.88

u/ml

—

Appendicitis, broad definition

654

1.10

0.36

1.0

1.1

—

36.88

u/ml

—

Labour and delivery complicated by umbilical cord complications

1.33

0.33

1.0

—

Pregnancy with abortive outcome

386

1.10

0.31

1.1

—

33.38

u/ml

—

Other noninflammatory disorders of vulva and perineum

1.30

0.30

1.0

1.1

—

Bronchitis, not specified as acute or chronic

1.30

0.30

1.1

1.0

—

Exposure to other specified factors

655

1.09

0.28

1.1

—

31.00

—

Diabetic retinopathy

158

1.16

0.27

1.1

—

u/ml

—

Later onset COPD

154

1.17

0.26

1.0

1.1

—

Uterine polyps

1.23

0.25

1.0

1.1

—

Exposure to unspecified factor

104

758

1.06

0.23

1.1

—

31.00

u/ml

—

Unspecified abortion

1.28

0.23

1.0

1.1

—

Caries in Clefts patients

0.00

0.21

0.0

1.2

—

Other diseases caused by chlamydiae

0.00

0.21

0.0

1.2

—

Carcinoma in situ of breast, other/unspecified

0.00

0.21

0.0

1.0

—

Conotruncal defects

0.00

0.21

0.0

1.2

—

Assault by blunt object

0.00

0.21

0.0

1.2

—

Hydatidiform mole

0.00

0.21

0.0

1.1

—

Abnormal findings in nipple discharge synovial fluid wound secretions

0.00

0.21

0.0

1.2

—

Mandibular prognathia

0.00

0.21

0.0

1.2

—

Disorders in reading

0.00

0.21

0.0

1.1

—

Cleft lip, lip and palate or palate

0.00

0.21

0.0

1.2

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

0.21

0.0

1.2

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.00

0.21

0.0

1.2

—

Human immunodeficiency virus [HIV] disease

0.00

0.21

0.0

1.2

—

Benign neoplasm: Vulva

0.00

0.21

0.0

1.2

—

Habitual aborter

0.00

0.21

0.0

1.1

—

Autism spe, excluding more controls

0.00

0.21

0.0

1.1

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

0.21

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

544

0.92

0.21

1.1

—

31.00

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.21

0.0

1.2

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.21

0.0

1.2

—

Other and unspecified mental retardation

0.00

0.21

0.0

1.2

—

Assault by unspecified means

0.00

0.21

0.0

1.2

—

Iron deficiency

0.00

0.21

0.0

1.2

—

Conduct disorder

0.00

0.21

0.0

1.1

—

Mixed disorders of conduct and emotions

0.00

0.21

0.0

1.1

—

Benign neoplasm of ovary

156

0.83

0.21

1.2

1.1

—

Anorexia

0.00

0.21

0.0

1.2

—

Other disorders of breast and lactation associated with childbirth

0.00

0.21

0.0

1.1

—

Benign neoplasm: Vulva

0.00

0.21

0.0

1.2

—

Behavioural disorders

0.00

0.21

0.0

1.2

—

Mental and behavioural disorders due to cannabinoids

0.00

0.21

0.0

1.2

—

0.00

0.20

0.0

1.1

—

Wide developmental disorders, excluding more controls

0.00

0.20

0.0

1.2

—

Benign neoplasm of breast

112

0.80

0.20

1.0

1.1

—

Persons encountering health services in circumstances related to reproduction

353

0.92

0.19

1.0

1.1

—

8.86

u/ml

—

Unspecified lump in breast

132

0.83

0.18

1.1

—

Antepartum haemorrhage, not elsewhere classified

1.15

0.17

1.1

—

u/ml

—

COPD-related respiratory insufficiency

1.11

0.16

1.0

—

Diabetic neuropathy

1.10

0.16

1.0

1.1

—

Antenatal screening

115

0.88

0.15

1.0

1.2

—

9.40

u/ml

—

Infections of genitourinary tract in pregnancy

1.08

0.14

1.0

1.1

—

Benign neoplasm of breast

109

0.83

0.13

1.0

1.1

—

Tooth eruption problems

1.15

0.10

1.3

1.1

—

9.80

u/ml

—

Other maternal disorders predominantly related to pregnancy

394

0.96

0.09

1.1

—

33.11

u/ml

—

Inflammatory disease of cervix uteri

1.11

0.09

1.0

1.1

—

Carcinoma in situ of cervix uteri

0.83

0.08

1.0

1.1

—

Carcinoma in situ of cervix uteri

0.81

0.08

1.0

1.1

—

Injuries to the knee and lower leg

130

727

1.02

0.07

1.1

—

28.45

u/ml

—

LSIL lesion of the cervix uteri

0.85

0.07

1.1

—

malignant neoplasm of female genital organs

130

0.92

0.04

1.1

—

Diabetic retinopathy, strict definition

108

1.06

0.01

1.1

—

Care involving use of rehabilitation procedures

566

0.99

0.00

1.1

—

36.88

u/ml

—

Fracture of lower leg, including ankle

503

1.01

0.00

1.0

1.1

—

23.29

—

Chronic myringitis

0.00

0.0

1.2

—

Neuroendocrine tumor and carcinoma of lung

0.00

0.0

1.2

—

Other/unspecified mastoiditis and related conditions

0.00

0.0

1.2

—

Other and unspecified neuropathies

0.00

0.0

1.2

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

0.0

1.0

—

Use of amantadine

0.00

0.0

1.2

—

Lack of expected normal physiological development

0.00

0.0

1.0

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

0.0

1.2

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.0

1.2

—

Motor disorders

0.00

0.0

1.3

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.0

1.0

—

Occlusion and stenosis of arteries, not leading to stroke

0.00

0.0

1.2

—

Histrionic personality disorder

0.00

0.0

1.2

—

Benign neoplasm: Brain, unspecified

0.00

0.0

1.3

—

Other benign neoplasm of uterus: Cervix uteri

0.00

0.0

1.2

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.2

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.0

1.2

—

Cleft lip and cleft lip and palate

0.00

0.0

1.2

—

Assault by other specified means

0.00

0.0

1.3

—

0.00

0.0

1.4

—

Measles

0.00

0.0

1.2

—

Benign neoplasm: Mediastinum

0.00

0.0

1.2

—

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Acquired stenosis of external ear canal

0.00

0.0

1.2

—

Mesial bite

0.00

0.0

1.3

—

Brain astrocytoma

0.00

0.0

1.4

—

Carcinoma in situ of endometrium

0.00

0.0

1.4

—

Defect, injury or illness of lumbar spine

0.00

0.0

1.2

—

Degenerative myopia

0.00

0.0

1.2

—

Diseases caused by chlamydiae

0.00

0.0

1.1

—

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.0

1.2

—

Acromegaly and pituitary gigantism

0.00

0.0

1.2

—

Vascular dementia (mixed)

0.00

0.0

1.0

—

Respiratory distress of newborn

0.00

0.0

1.2

—

Right ventricular outflow tract obstruction

0.00

0.0

1.4

—

Behavioural disorders, excluding more controls

0.00

0.0

1.1

—

Whooping cough

0.00

0.0

1.3

—

Melanoma in situ of upper limb, including shoulder

0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.0

1.2

—

Leukaemia of unspecified cell type

0.00

0.0

1.0

—

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.0

1.1

—

Carcinoma in situ of breast

0.00

0.0

1.2

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.0

—

Benign neoplasm: Retina

0.00

0.0

1.3

—

Benign neoplasm: Retina

0.00

0.0

1.2

—

Benign neoplasm: Connective and other soft tissue of thorax

0.00

0.0

1.2

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.00

0.0

1.2

—

Ovarian dysfunction, other/unspecified

0.00

0.0

1.4

—

Melanocytic naevi of eyelid, including canthus

0.00

0.0

1.1

—

Benign neoplasm: Spinal meninges

0.00

0.0

1.0

—

Other benign neoplasm of uterus: Corpus uteri

0.00

0.0

1.0

—

Routine general health check-up of defined subpopulation

0.00

0.0

1.0

—

Right side

0.00

0.0

1.2

—

Carcinoma in situ of vulva

0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Histone Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS